Revvity Newsroom

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Revvity (RVTY) and McKesson (MCK)

TipRanksDec 6 14:03

Stifel Nicolaus Remains a Hold on Revvity (RVTY)

TipRanksNov 28 15:50

Revvity Is Maintained at Overweight by Barclays

Dow JonesNov 25 22:51

Revvity Analyst Ratings

BenzingaNov 25 22:42

Barclays Maintains Revvity(RVTY.US) With Buy Rating, Cuts Target Price to $135

Futu NewsNov 25 20:39

Barclays Adjusts Price Target on Revvity to $135 From $140, Keeps Overweight Rating

MT NewswiresNov 25 19:56

Revvity (RVTY) Receives a Buy From Barclays

TipRanksNov 25 19:37

Strategic Growth and Innovation Drive Puneet Souda's Buy Rating for Revvity

TipRanksNov 25 13:49

TD Cowen Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $144

Futu NewsNov 22 20:31

Revvity (RVTY) Gets a Buy From TD Cowen

TipRanksNov 22 20:27

Nephron Downgrades Revvity(RVTY.US) to Sell Rating, Cuts Target Price to $105

Futu NewsNov 12 00:31

Revvity's Resilience and Growth Potential: A Buy Rating Amidst Challenges

TipRanksNov 6 16:19

Revvity Is Maintained at Outperform by Raymond James

Dow JonesNov 6 02:13

UBS Raises Revvity Price Target to $145 From $140, Maintains Neutral Rating

MT NewswiresNov 6 00:32

Raymond James Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $146

Futu NewsNov 5 23:31

TD Cowen Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $144

Futu NewsNov 5 21:38

Bernstein Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $145

Futu NewsNov 5 21:38

Analysts Offer Insights on Healthcare Companies: Supernus Pharmaceuticals (SUPN), Editas Medicine (EDIT) and Revvity (RVTY)

TipRanksNov 5 21:36

A Quick Look at Today's Ratings for Revvity(RVTY.US), With a Forecast Between $132 to $145

Futu NewsNov 5 21:08

Revvity Analyst Ratings

BenzingaNov 5 20:08